Global Laser Indirect Ophthalmoscope Market - 2024-2031

Global Laser Indirect Ophthalmoscope Market - 2024-2031

Global Laser Indirect Ophthalmoscope Market reached US$ XX million in 2023 and is expected to reach US$ XX million by 2031, growing at a CAGR of XX% during the forecast period 2024-2031

Laser Indirect Ophthalmoscopes produce dazzling exposures and transient afterimages, but there is no evidence that they cause photochemical or thermal retinal injury in routine clinical use. A 15-minute exposure focused on a single retinal area can cause localized phototoxic injury in an anesthetized rhesus monkey. Still, no immediate or long-term retinal abnormalities could be detected in human volunteers with blind eyes or those requiring enucleation.

Market Dynamics: Drivers & Restraints

Rise of advancements in laser indirect ophthalmoscope

Technological advancements in laser indirect ophthalmoscopes, such as improved image quality, portability, and ease of use, are also contributing to the market's growth. These advancements make the devices more accessible and attractive to healthcare providers. Technologies like digital imaging and augmented reality are enhancing the capabilities of laser indirect ophthalmoscopes, allowing for better visualization and diagnosis of eye conditions.

For instance, Norlase has introduced the LION, a new laser indirect ophthalmoscope (LIO) that combines a green laser photocoagulator with a Keeler indirect ophthalmoscope. This battery-powered LIO requires no fiber tether and uses an advanced wireless interface with voice control of parameters. This allows ophthalmologists to experience an untethered, lightweight, and portable laser treatment solution virtually anywhere.

Regulatory challenges

The laser indirect ophthalmoscope faces numerous regulatory challenges in the market. These include obtaining FDA clearance for new models, meeting safety and performance standards set by regulatory bodies, adhering to labeling and documentation requirements, navigating differing regulatory frameworks across countries, and managing increased regulatory scrutiny as more advanced models are introduced. These challenges add time and costs to the development process and complicate global commercialization efforts for laser indirect ophthalmoscope makers.

Segment Analysis

The global laser indirect ophthalmoscope market is segmented based on laser type, therapeutic application, end-user, and region.

The photocoagulation laser from the laser type segment accounted for approximately 42.3% of the laser indirect ophthalmoscope market share

The photocoagulating laser from the laser type segment accounted for approximately 42.3%. Photocoagulation lasers, like argon and diode lasers, are widely used to treat retinal conditions like diabetic retinopathy and retinal vein occlusion by sealing blood vessels and reducing vision loss risk. This segment is expected to dominate due to increasing retinal disease incidence and photocoagulation therapy effectiveness.

For instance, in May 2023, Norlase, a leading global ophthalmic laser manufacturer developing next-generation laser solutions, announced it had received both FDA 510(k) clearance and CE Mark approval for the ECHO Green Pattern Laser photocoagulator.

Geographical Analysis

North America is estimated to hold about 38.4% of the total market share throughout the forecast period

North America is estimated to hold about 38.4% of the total market share throughout the forecast period owing to factors like novel product launches, investment by key players, advanced healthcare infrastructure, high adoption of advanced medical technologies, and increasing healthcare expenditure. However, rapid economic development, growing healthcare investments,

For instance, in May 2023, Norlase, a leading laser technology company, secured its largest investment round to date, raising $11 million. The funding will enable Norlase to accelerate the production of its ECHO pattern laser, which has received FDA clearance and CE Mark. The investment will also advance Norlase's laser treatment solution portfolio. West Hill Capital led the round.

Market Segmentation

By Laser type
• Photocoagulation laser
• Photo disrupting laser
• Photo ablating laser

By Therapeutic Application
• Diabetic retinopathy
• Cataract
• Corneal opacities
• Glaucoma
• Pediatric retinal repairs
• Lattice degeneration

By End User
• Hospitals
• Ophthalmic Clinics
• Ambulatory Surgery Centers (ASCs)
• Others

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
UK
France
Italy
Spain
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The major global players in the market include Iridex Corporation, Meridian AG, Lumenis, Ellex Medical Lasers, Carl Zeiss Meditec AG, Nidek Co. Ltd., Ziemer Ophthalmic Systems AG, Heine Optotechnik GmbH, Keeler Ltd, Topcon Medical Laser Systems Inc among others.

Key Developments

 In January 2021, Norlase announced that it had been granted the European CE Mark for the LION green laser system. LION combines the Keeler Vantage Plus diagnostic indirect with Norlase’s groundbreaking compact laser technology into one device. With LION’s untethered and portable design, physicians can move freely between treatment rooms – conveniently treating patients anywhere, anytime.

Why Purchase the Report?
• To visualize the global laser indirect ophthalmoscope market segmentation based on laser type, therapeutic application, end user, and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• excel data sheet with numerous data points of the laser indirect ophthalmoscope market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.

The global laser indirect ophthalmoscope market report would provide approximately 64 tables, 61 figures, and 186 pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies